Ontology highlight
ABSTRACT: Background
Circulating creatinine and symmetric dimethylarginine (SDMA) are biomarkers of kidney function that have been used variously to define stable vs progressive chronic kidney disease (CKD). Slope monitoring of inverse biomarker values (creatinine-1 or SDMA-1 ) has shown promise, but quantitative criteria to distinguish stable vs progressive CKD using this approach are lacking.Objective
Assessment of creatinine-1 and SDMA-1 slope cutoffs to distinguish stable vs progressive CKD.Animals
One hundred ten clinically healthy university staff-owned dogs and 29 male colony dogs with progressive X-linked hereditary nephropathy (XLHN).Methods
Retrospective analysis combining 2 prospective observational studies, 1 tra
SUBMITTER: Cowgill LD
PROVIDER: S-EPMC10658543 | biostudies-literature | 2023 Nov-Dec
REPOSITORIES: biostudies-literature